Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Healthcare REITs Industry Analysis

UpdatedSep 10, 2026
DataAggregated Company Financials
Companies18
  • 7D-1.6%
  • 3M8.5%
  • 1Y25.6%
  • YTDn/a

Over the last 7 days, the Healthcare REITs industry has dropped 1.4%, driven by Welltower declining 1.3%. In the past year, the industry has gained 26%. Looking forward, earnings are forecast to grow by 19% annually.

Industry Valuation and Performance

Has the U.S. Healthcare REITs Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 10 Sep 2026US$311.6bUS$36.1bUS$2.4b29.4x131.7x8.6x
Sat, 08 Aug 2026US$311.1bUS$36.1bUS$2.3b30.8x138.1x8.6x
Mon, 06 Jul 2026US$306.5bUS$34.5bUS$1.6b35.6x194.2x8.9x
Wed, 03 Jun 2026US$266.7bUS$34.7bUS$1.6b38.1x165x7.7x
Fri, 01 May 2026US$277.0bUS$34.3bUS$1.3b51x220.9x8.1x
Sun, 29 Mar 2026US$250.4bUS$32.5bUS$355.1m35.4x704.9x7.7x
Tue, 24 Feb 2026US$266.7bUS$32.7bUS$172.2m46.1x1548.4x8.2x
Thu, 22 Jan 2026US$244.0bUS$31.5bUS$440.3m33x554.3x7.8x
Sat, 20 Dec 2025US$240.4bUS$31.5bUS$440.3m32.3x546x7.6x
Mon, 17 Nov 2025US$245.5bUS$31.5bUS$434.8m31.9x564.7x7.8x
Wed, 15 Oct 2025US$217.5bUS$30.4bUS$354.3m30.5x614x7.2x
Fri, 12 Sep 2025US$223.4bUS$30.4bUS$354.3m33.7x630.7x7.3x
Sun, 10 Aug 2025US$216.7bUS$30.8bUS$332.7m30x651.5x7x
Tue, 08 Jul 2025US$200.6bUS$29.4bUS$68.9m36.8x2911.3x6.8x
Thu, 05 Jun 2025US$197.0bUS$29.7bUS$181.8m32.2x1083.4x6.6x
Sat, 03 May 2025US$198.8bUS$29.5bUS$80.6m33.3x2468.2x6.7x
Mon, 31 Mar 2025US$205.3bUS$28.7b-US$1,068,162,000.0035x-192.2x7.1x
Wed, 26 Feb 2025US$198.9bUS$28.2b-US$1,446,498,000.0035x-137.5x7.1x
Fri, 24 Jan 2025US$179.7bUS$27.4b-US$1,625,663,000.0040.8x-110.6x6.6x
Sun, 22 Dec 2024US$175.5bUS$27.4b-US$1,625,663,000.0041.3x-107.9x6.4x
Tue, 19 Nov 2024US$189.1bUS$27.4b-US$1,625,662,000.0044.1x-116.3x6.9x
Thu, 17 Oct 2024US$188.6bUS$26.2b-US$1,429,354,000.0055.3x-131.9x7.2x
Sat, 14 Sep 2024US$187.1bUS$26.2b-US$1,429,354,000.0054.5x-130.9x7.1x
Mon, 12 Aug 2024US$170.9bUS$26.2b-US$1,481,003,000.0049.9x-115.4x6.5x
Wed, 10 Jul 2024US$153.7bUS$26.1b-US$1,195,454,000.0044.5x-128.5x5.9x
Fri, 07 Jun 2024US$153.0bUS$26.1b-US$1,195,454,000.0042.1x-128x5.9x
Sun, 05 May 2024US$123.6bUS$23.1b-US$274,609,000.0040.5x-450.2x5.4x
Tue, 02 Apr 2024US$117.8bUS$22.6b-US$276,709,000.0043.2x-425.7x5.2x
Thu, 29 Feb 2024US$113.9bUS$23.1b-US$214,887,000.0036.6x-529.9x4.9x
Sat, 27 Jan 2024US$113.6bUS$24.3bUS$48.6m44.4x2337.6x4.7x
Mon, 25 Dec 2023US$118.8bUS$24.3bUS$48.6m47.2x2445.5x4.9x
Wed, 22 Nov 2023US$111.2bUS$24.3bUS$48.6m39.9x2289.7x4.6x
Fri, 20 Oct 2023US$105.4bUS$23.9bUS$463.1m28.4x227.5x4.4x
Sun, 17 Sep 2023US$110.8bUS$24.0bUS$472.6m33.6x234.5x4.6x
Price to Earnings Ratio

234.5x


Total Market Cap: US$110.8bTotal Earnings: US$472.6mTotal Revenue: US$24.0bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthcare REITs Industry Price to Earnings3Y Average 371.4x202420252026
Current Industry PE
  • Investors are pessimistic on the American Health Care REITs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 131x which is lower than its 3-year average PE of 371x.
  • The 3-year average PS ratio of 6.7x is lower than the industry's current PS ratio of 8.6x.
Past Earnings Growth
  • The earnings for companies in the Health Care REITs industry have grown 71% per year over the last three years.
  • Revenues for these companies have grown 15% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does U.S. Healthcare REITs compare with similar industries?

US Market-0.22%
Real Estate-1.03%
REITS-1.16%
Healthcare REITs-1.60%
Residential REITs0.36%
Industrial REITs-0.80%
Hotel and Resort REITs-0.90%
Diversified REITs-1.16%
Specialized REITs-1.65%
Retail REITs-1.99%
Office REITs-3.71%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
JAN Janus LivingUS$31.001.0%
+US$69.6m		n/aPB2.6x
OHI Omega Healthcare InvestorsUS$47.190.4%
+US$60.6m		10.2%PB2.7x
LTC LTC PropertiesUS$42.552.4%
+US$52.8m		16.4%PB1.8x
NHP National Healthcare PropertiesUS$16.250.7%
+US$8.0m		n/aPB1.1x
STRW Strawberry Fields REITUS$13.912.3%
+US$4.4m		20.1%PB23.9x

Latest News

STRW
US$13.91
Strawberry Fields REIT
7D
2.3%
1Y
20.1%
AHR
US$53.77
American Healthcare REIT
7D
-4.3%
1Y
24.6%
MPT
US$3.90
Medical Properties Trust
7D
-3.9%
1Y
-15.4%
Narrative Update • Sep 09

MPT: Hospital Cash Flows And Share Buybacks Will Test Execution Resilience

Analysts recently trimmed their fair value estimate for Medical Properties Trust to $3.80 from $4.50, citing updated views on hospital cash flow pressures, a slightly higher discount rate and lower projected profit margins despite a less steep expected revenue decline. Analyst Commentary Recent Street research on Medical Properties Trust points to a cautious stance, with several bearish analysts trimming valuation assumptions and price targets.
LTC
US$42.55
LTC Properties
7D
2.4%
1Y
16.4%
Seeking Alpha • Sep 06

LTC Properties Upgraded To Buy, A Monthly Income Opportunity Driven By Senior Care (Rating Upgrade)

Summary LTC Properties is upgraded to a buy, driven by demographic tailwinds, portfolio growth, monthly dividends, and recent Deutsche Bank upgrade. LTC's strategic shift toward independent and assisted living, and less on skilled nursing, optimizes risk and targets a growing market segment. Strong top-line and FFO growth, diversified geographic exposure, and manageable leverage underpin LTC's bullish outlook despite some operator concentration risks. A higher yield, monthly payouts, and market outperformance make LTC compelling, though supply dynamics and operator execution remain key risks. Read the full article on Seeking Alpha
JAN
US$31.00
Janus Living
7D
1.0%
1Y
n/a
DOC
US$20.39
Healthpeak Properties
7D
-3.0%
1Y
13.6%
Narrative Update • Sep 04

DOC: Buybacks And Capital Partnership Will Support Measured Future Upside Potential

Analysts have lifted their fair value estimate for Healthpeak Properties from $21.44 to $23.05, citing updated assumptions around revenue growth, profit margins, and future P/E levels as the key drivers of the higher price target. What's in the News for Healthpeak Properties Healthpeak Properties announced a share repurchase program that authorizes the company to buy back up to $500 million of its stock.
ARE
US$50.34
Alexandria Real Estate Equities
7D
-4.5%
1Y
-40.1%
Narrative Update • Sep 03

ARE: New Index Inclusion And Funding Plans Will Shape Measured Upside Potential

Analysts have raised their price target for Alexandria Real Estate Equities to $53 from $51, citing changes in fair value estimates, revised discount rate assumptions, and updated expectations for profit margins and future P/E levels. What’s in the News for Alexandria Real Estate Equities Alexandria Real Estate Equities appointed multiple firms, including Scotia Capital USA, Truist Securities, Mizuho Securities USA, SMBC Nikko Securities America, BNP Paribas Securities Corp., TD Securities USA, BBVA Securities, PNC Capital Markets, and U.S. Bancorp Investments, as co lead underwriters for its planned US$1b fixed income offering.
VTR
US$89.38
Ventas
7D
-2.9%
1Y
29.1%
Narrative Update • Sep 03

VTR: Index Additions And Stable 2026 Guidance Support Balanced Return Profile

Analysts have adjusted their fair value estimate for Ventas to $101.86 from $99.05, reflecting updated views on the company’s discount rate, revenue growth assumptions, profit margin outlook, and future P/E expectations. What’s in the News for Ventas Ventas revised its full year 2026 guidance for attributable net income per share to a range of $0.58 to $0.63, with a midpoint of $0.61.
WELL
US$235.90
Welltower
7D
-1.1%
1Y
40.3%
Narrative Update • Sep 03

WELL: Higher Multiple And Ongoing Equity Issuance Will Temper Forward Returns

Analysts have raised their price target for Welltower to $231.61 from $210.69, citing updated assumptions for fair value, revenue growth, profit margin and future P/E as the main drivers of this change. What’s in the News for Welltower Welltower completed a follow on equity offering of approximately US$6.63b through an at the market program, issuing multiple tranches of common stock at price ranges from about US$186.60 to US$233.16 per share.
OHI
US$47.19
Omega Healthcare Investors
7D
0.4%
1Y
10.2%
NHP
US$16.25
National Healthcare Properties
7D
0.7%
1Y
n/a
New Narrative • Aug 25

Senior Housing Concentration And Rising Costs Will Shape Future Returns Here

Catalysts About National Healthcare Properties National Healthcare Properties focuses on senior housing communities with an emphasis on private pay, higher-acuity care within a SHOP oriented REIT structure. What are the underlying business or industry changes driving this perspective?
HR
US$18.91
Healthcare Realty Trust
7D
-2.0%
1Y
3.2%
XRN
US$36.98
Chiron Real Estate
7D
0.2%
1Y
-3.2%
CTRE
US$39.04
CareTrust REIT
7D
-1.3%
1Y
15.3%
Seeking Alpha • Aug 18

CareTrust: Buy The Dip On This Income And Growth Machine

Summary CareTrust REIT is upgraded to 'Buy' after a price pullback, offering a rare blend of yield and high growth. CTRE's diversified platform, robust pipeline, and focus on quality operators underpin 16% FFO/share growth guidance for 2026. A strong balance sheet and 4% yield support continued dividend growth and total return potential. Despite trading at an 18.95x forward P/FFO premium, demographic tailwinds and disciplined acquisitions justify expectations for double-digit annualized returns. Read the full article on Seeking Alpha